Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
The British Journal of Dermatology|March 1, 1987
The localization of the binding site of circulating IgA antibodies in linear IgA disease of adults, chronic bullous disease of childhood and childhood cicatricial pemphigoidJ Aboobaker, B Bhogal, F Wojnarowska, et al.Acta Dermato-Venereologica|January 1, 1988
Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled studyA Kobza Black, J Aboobaker, J R Gibson, et al.Tropical Medicine & International Health : TM & IH|February 13, 2010
A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to childrenL M Butler, T B Neilands, A Mosam, et al.Blood Advances|March 9, 2021
Platelets as drivers of ischemia/reperfusion injury after strokeNoor F Shaik, Raymond F Regan, Ulhas P NaikAnnals of Neurology|June 16, 2025
Characterization of Neuropsychiatric Conditions in United States Resettled Refugees at a Single Academic CenterNoor F Shaik, Uttara Gadde, Aba Y Barden-MajaNeurology|October 24, 2024
Global and Community Health: Neurologic Care and a Case Study for Immigrants and Refugees in West PhiladelphiaNoor F Shaik, Yombe Fonkeu, Jonathan Perkins, et al.International Journal of Dermatology|January 13, 2000
Erythroderma: a comparison between HIV positive and negative patientsN Morar, N Dlova, A K Gupta, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 30, 2010
Guideline on the management of psoriasis in South AfricaN Raboobee, J Aboobaker, H F Jordaan, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 24, 2017
Primary cutaneous malignancies in the Northern Cape Province of South Africa: A retrospective histopathological reviewK York, N C Dlova, C Y Wright, et al.Pediatric Dermatology|December 12, 2001
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazoleA K Gupta, P Adam, N Dlova, et al.Pageof 5